Davita Inc Intrinsic Value Calculation – Nordea Investment Management AB Trims Holdings in DaVita by 2.6% in Q1

🌥️Trending News

DAVITA ($NYSE:DVA): As the largest provider of home dialysis services with its expert network of nephrology physicians, the company provides outstanding patient care with an emphasis on top quality outcomes. Nordea Investment Management AB, an investment management company based in Sweden, recently reduced their stake in DaVita Inc. by 2.6%, as disclosed in their filing with the Securities and Exchange Commission. While this may result in a smaller return on their investment in the short term, it could potentially lead to greater returns in the long run.

Analysis – Davita Inc Intrinsic Value Calculation

At GoodWhale, we have conducted an in-depth analysis of DAVITA INC‘s fundamentals. Our proprietary Valuation Line indicates that the intrinsic value of DAVITA INC shares is around $100.9. This means that the current market price of $100.8 represents fair value. We believe that investing in DAVITA INC shares at this level is a good opportunity for investors. More…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Davita Inc. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Davita Inc. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Davita Inc. More…

Key Ratios Snapshot

Some of the financial key ratios for Davita Inc are shown below. More…

Peers

In the dialysis industry, DaVita Inc. competes with Acadia Healthcare Co Inc, Fresenius Medical Care AG & Co. KGaA, Medical Facilities Corp, and other companies. The company has a network of 2,664 outpatient dialysis centers in the United States that serve approximately 198,000 patients with end-stage renal disease.

– Acadia Healthcare Co Inc ($NASDAQ:ACHC)

Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services. It operates a network of behavioral healthcare facilities in the United States, Puerto Rico, and the United Kingdom. The company offers inpatient psychiatric and substance abuse services, residential treatment, outpatient behavioral health services, and specialty behavioral healthcare services.

– Fresenius Medical Care AG & Co. KGaA ($LTS:0H9X)

Fresenius Medical Care AG & Co. KGaA, a renal care company, provides products and services for patients with renal diseases worldwide. The company’s products and services include dialysis machines, dialyzers, and related disposable products, as well as renal pharmaceuticals. It also offers clinical laboratory testing services. The company was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.

– Medical Facilities Corp ($TSX:DR)

Medical Facilities Corporation is a leading operator of specialty surgical hospitals and ancillary services in the United States. The company owns and operates seven specialty surgical hospitals, one surgical hospital, and three surgical facilities located in Arkansas, Illinois, Louisiana, Mississippi, Oklahoma, and Texas. Medical Facilities Corporation’s hospitals offer a broad range of services, including general surgery, cardiovascular surgery, orthopedic surgery, pain management, gastroenterology, urology, and otolaryngology. The company’s hospitals are accredited by the Joint Commission on Accreditation of Healthcare Organizations and are licensed by the respective state Departments of Health.

Summary

An analysis of investments in Davita Inc. has revealed that Nordea Investment Management AB decreased its ownership in the company by 2.6% in the first quarter. This suggests that the company may not be performing as well as initially anticipated. Investors should keep an eye on the performance of Davita Inc. to determine whether or not it is a worthwhile investment. Additionally, they should consider other factors such as risk management, cost efficiency and competitive landscape before investing in the company.